Australia (AU)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fast-growing species shape the evolution of reef corals (2022) Siqueira AC, Kießling W, Bellwood DR Journal article Shared decision-making in the realm of uncertainty: The example of coronary artery disease through an EBM and complexity science lens (2022) Sturmberg JP, Kissling B, Kühlein T Journal article Metasurfaces for photonic devices (2022) Staude I, Chen H, Miroshnichenko A, Takahara J, Padilla WJ Journal article Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range (2022) Mahfoud F, Mancia G, Schmieder R, Ruilope L, Narkiewicz K, Schlaich M, Williams B, et al. Journal article WHO 2022 classification of penile and scrotal cancers: updates and evolution (2022) Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, Comperat E, et al. Journal article In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting FOXP2 (2022) Morison LD, Meffert E, Stampfer M, Steiner-Wilke I, Vollmer B, Schulze K, Briggs T, et al. Journal article Evidence of ACL healing on MRI following ACL rupture treated with rehabilitation alone may be associated with better patient-reported outcomes: a secondary analysis from the KANON trial (2022) Filbay SR, Roemer F, Lohmander LS, Turkiewicz A, Roos EM, Frobell R, Englund M Journal article In-fibre second-harmonic generation with embedded two-dimensional materials (2022) Ngo GQ, Najafidehaghani E, Gan Z, Khazaee S, Siems MP, George A, Schartner EP, et al. Journal article WHO working definition of vitality capacity for healthy longevity monitoring (2022) Bautmans I, Knoop V, Thiyagarajan JA, Maier AB, Beard JR, Freiberger E, Belsky D, et al. Journal article GeparPiPPa- A randomized, open-label, phase II trial comparing neoadjuvant trastuzumab, pertuzumab and endocrine therapy +/- the PI3K inhibitor inavolisib in patients (pts) with HER2+/HR+, PIK3CA mutant early breast cancer (BC) (2022) Loibl S, Reinisch M, Denkert C, Schneeweiss A, Seiler S, Fasching P, Hanusch C, et al. Conference contribution